GAINESVILLE, Fla., Jan. 14, 2005 (PRIMEZONE) -- Mammatech Corporation (OTCBB:MAMM), which pioneered The MammaCare(r) program for early breast cancer detection in Europe and the U.S., has been approved for listing on the Frankfurt Stock Exchange (Freiverkehr). The company's shares will began trading this week on the Frankfurt Exchange at under the name Mammatech, trading symbol NBN1. The ISIN/CUSIP number is US5615082014.
Mammatech's U.S. trademark, MammaCare(r) is registered in the EU Common Market
Mammatech's chairman, Dr. Mark Goldstein, remarked that the Frankfurt Exchange listing is an important step toward providing greater liquidity for Mammatech's European shareholder base. "European investors are showing interest because the MammaCare program is gaining popularity in Europe. MammaCare is practiced at leading medical institutions in Frankfurt and in Munich. Investors will now have easier access to trade Mammatech's shares. We made a commitment to European women and to investors to have our breast cancer screening technology available in the EU and our shares listed on a major European exchange. We are pleased to deliver on these commitments."
N.M. Fleischhacker AG in Frankfurt is the specialist for the trading of Mammatech's shares on the Frankfurt Exchange. The German Securities Code is A0DNUV.
About Mammatech:
The Company's MammaCare(r) program is the standard for effective Clinical Breast Examination (CBE) and breast self-examination (BSE). In Frankfurt, MammaCare is practiced at Clinic for Gynocology und Obstetrics at The Wolfgang Goethe-University Medical School. In Munich, MammaCare is practiced at The Womens Clinic of the Technical University.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
The matters discussed here contain forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and information relating to the company that is based on the beliefs of the management of the company, as well as assumptions made by and information currently available to the management of the company. When used in this presentation, the words "anticipates," "intends," and similar expressions are intended to identify forward-looking statements. Such statements reflect the current views of the company with respect to future events, and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. The company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.